[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100434198":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":26,"centralContacts":30,"locations":39,"responsibleParty":67,"collaborators":25,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":25,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":89,"overallStatus":42,"whyStopped":25,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Centre Hospitalier Henri Laborit","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Active stimulation","EXPERIMENTAL","Active rTMS stimulation , 2 session per day during 10 days.",[13],"Device: rTMS Treatment",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham Stimulation","SHAM_COMPARATOR","Sham rTMS stimulation , 2 session per day during 10 days.",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","rTMS Treatment","1 Hz rTMS",[9,15],null,[27],{"name":28,"affiliation":5,"role":29},"Ghina Harika-Germaneau","STUDY_DIRECTOR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Ghina Harika-Germaneau, MD, PhD","CONTACT","+33 5 16 52 61 18","ghina.harika.germaneau@ch-poitiers.fr",{"name":37,"role":33,"phone":34,"phoneExt":25,"email":38},"Nematollah Jaafari, PR","nemat.jaafari@ch-poitiers.fr",[40,56],{"facility":41,"status":42,"city":43,"state":25,"zip":25,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Sorbonne University, Pitié-Salpêtrière Hospital","RECRUITING","Paris","France","FR",{"type":47,"coordinates":48},"Point",[49,50],2.3488,48.85341,{"lat":50,"lon":49},[53],{"name":54,"role":33,"phone":25,"phoneExt":25,"email":55},"Bruno Millet, PR","b.millet@aphp.fr",{"facility":5,"status":42,"city":57,"state":25,"zip":58,"country":44,"countryCode":45,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Poitiers","86021",{"type":47,"coordinates":60},[61,62],0.34348,46.58261,{"lat":62,"lon":61},[65],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":66},"ghina.harika-germaneau@ch-poitiers.fr",{"type":68,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100434198","bilateral-lateral-ofc-rtms-in-obsessive-compulsive-disorder-100434198",false,"NCT04934007","Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder","A Randomized Control Trial of Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder","ORBITOC3","Inclusion Criteria:\n\n* Age: Participants will be both males and females, 18-65 years of age included.\n* diagnosis of OCD\n* all the patients must have failed to respond to at least two different pharmacological treatment used for at least 6 weeks\n* Affiliation to a social security system (recipient or assignee),\n* Signed written inform consent form\n\nExclusion Criteria:\n\n* The exclusion criteria are a diagnosis of another psychiatric disorder (except for anxious disorders), a diagnosis of a significant active medical illness, pregnancy or other neurological illness\n* In accordance with the safety criteria for rTMS, patients with a history of seizure or bearing pacemakers, mobile metal implants, implanted medical pumps, or metal clips placed inside the skull will also be excluded\n* The patients won't be allowed to change their medication during the trial. The treatment must be stable at least 3 week before day 0.\n* Female subject who is pregnant, or of child-bearing age, sexually active and not using reliable contraception or who is nursing,\n* Patient under curators\n* Patient hospitalized under duress\n* Patient unable to give his or hers informed consent","ALL","18 Years","65 Years",{"count":81,"type":82},136,"ESTIMATED","INTERVENTIONAL",[85],"NA","According to the literature the lateral part of the Orbito Frontal Cortex (lOFC) is a relevant bilateral target for repetitive Trans-cranial Magnetic Stimulation (rTMS) in Obsessive Compulsive Disorder (OCD). Both hemispheres are concerned in terms of target.",[88],"Obsessive-Compulsive Disorder",[90,91],"rTMS","D-B80 A\u002FP","2026-01-12",{"date":94,"type":95},"2026-01-13","ACTUAL",{"date":97,"type":95},"2021-09-06",{"date":99,"type":82},"2027-09",{"name":5,"class":6},2]